Paweł Wańkowicz, Przemysław Nowacki


Glioblastoma multiforme is a particularly malignant form of primary brain tumor. This cancer represents 12–15% of all brain tumors. Despite advances in neurosurgery, radiation and chemotherapy, the average survival rate is only from 12.1 to 14.6 months. Glioblastoma multiforme is characterized by its diverse histological and cellular features. Like other malignant tumours, it is formed in a multi -stage process of somatic cell transformations, accumulating several genetic disorders. The last decade was a period of particular interest in stem cells. These cells have so far been identified in a variety of primary tumours in the brain. They are probably responsible for the recurrence and progression of cancer. Given the current state of knowledge, it is likely that modifications to the previously used morphological classification of tumours of the CNS will be made by the WHO, as well as the extension of its molecular criteria. In particular, such strategies are awaited for Glioblastoma multiforme – the most malignant primary tumor of the central nervous system, with so far very poor prognosis.


glioblastoma multiforme; the pathogenesis of cancer; genetic disorders; cancer stem cells

Full Text:

PDF (Język Polski)


Ohgaki H., Kleihues P.: Epidemiology and etiology of gliomas. Acta Neuropathol. 2005, 109 (1), 93–108.

Cokgor I., Friedman A.H., Friedman H.S.: Pediatric Update: Gliomas. Eur J Cancer. 1998, 34, 1910–1918.

Louis D.N., Pomeroy S.L., Cairncross I.G.: Focus on central nervous system neoplasia. Cancer Cell. 2002, 1 (2), 125–128.

Kleihues P., Cavenee W.K.: Pathology and genetics of tumours of the nervous system. IARC Press, Lyon 2000.

Rodriguez F.J., Orr B.A., Ligon K.L., Eberhart C.G.: Neoplastic cells are a rare component in human glioblastoma microvasculature. Oncotarget. 2012, 3, 98–106.

Stupp R., Mason W.P., van den Bent M.J., Weller M., Fisher B., Taphoorn M.J. et al.: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005, 352 (10), 987–996.

Scherer H.J.: Structural development in gliomas. Am J Cancer. 1938, 34, 333–351.

Zagzag D., Esencay M., Mendez O., Yee H., Smirnova I., Huang Y. et al.: Hypoxia - and vascular endothelial growth factor-induced stromal cell derived factor 1alpha/CXCR4 expression in glioblastomas: one plausible explanation of Scherer’s structures. Am J Pathol. 2008, 173, 545–560.

Burger P.C., Scheithauer B.W., Vogel F.S.: Surgical pathology of the nervous system and its coverings. Churchill Livingstone, New York 2002.

Louis D.N., Ohgaki H., Wiestler O.D., Cavenee W.K., Burger P.C., Jouvet A. et al.: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007, 114 (2), 97–109.

Wen P.Y., Kesari S.: Malignant gliomas in adults. N Engl J Med. 2008, 359 (5), 492–507.

Ohgaki H., Kleihues P.: Genetic pathways to primary and secondary glioblastoma. Am J Pathol. 2007, 170 (5), 1445–1453.

Smith J.S., Perry A., Borell T.J., Lee H.K., O’Fallon J., Hosek S.M. et al.: Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol. 2000, 18, 636–645.

Matise M.P., Joyner A.L.: Gli genes in development and cancer. Oncogene. 1999, 18, 7852–7859.

Yoon J.W., Kita Y., Frank D.J., Majewski R.R., Konicek B.A., Nobrega M.A. et al.: Gene expression profiling leads to identification of Gli1-binding elements in target genes and a role for multiple downstream pathways in Gli1-induced cell transformation. J Biol Chem. 2002, 277 (7), 5548–5555.

van den Boom J., Wolter M., Kuick R., Misek D.E., Youkilis A.S., We chsler D.S. et al.: Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription -polymerase chain reaction. Am J Pathol. 2003, 163 (3), 1033–1043.

Rickman D.S., Bobek M.P., Misek D.E., Kuick R., Blaivas M., Kurnit D.M. et al.: Distinctive molecular profiles of high grade and low grade gliomas based on oligonucleotide microarray analysis. Cancer Res. 2001, 61 (18), 6885–6891.

Ricci Vitiani L., Lombardi D.G., Pilozzi E., Biffoni M., Todaro M., Peschle C. et al.: Identification and expansion of human colon cancer -initiating cells. Nature. 2007, 445, 111–115.

Eramo A., Lotti F., Sette G., Pilozzi E., Biffoni M., Di Virgilio A. et al.: Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death and Differ. 2008, 15, 504–514.

Collins A.T., Berry P.A., Hyde C., Stower M.J., Maitland N.J.: Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005, 65, 10946–10951.

Li C., Heidt D.G., Dalerba P., Burant C.F., Zhang L., Adsay V. et al.: Identification of pancreatic cancer stem cells. Cancer Res. 2007, 67 (3), 1030–1037.

Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J. et al.: Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003, 63 (18), 5821–5828.

Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T. et al.: Identification of human brain tumour initiating cells. Nature. 2004, 432 (7015), 396–401.

Eriksson P.S., Perfilieva E., Bjork Eriksson T., Alborn A.M., Nordborg C., Peterson D. A. et al.: Neurogenesis in the adult human hippocampus. Nat Med. 1998, 4 (11), 1313–1317.

Doetsch F., Caille I., Lim D.A., Garcia Verdugo J.M., Alvarez Buylla A.: Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell. 1999, 97, 703–716.

Hamburger A.W., Salmon S.E.: Primary bioassay of human tumor stem cells. Science. 1977, 197 (4302), 461–463.

Galli R., Binda E., Orfanelli U., Cipelletti B., Gritti A., De Vitis S. et al.: Isolation and characterization of tumorigenic, stem -like neural precursors from human glioblastoma. Cancer Res. 2004, 64, 7011–7021.

Ignatova T.N., Kukekov V.G., Laywell E.D., Suslov O.N., Vrionis F.D., Steindler D.A.: Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia. 2002, 39 (3), 193–206.

Uchida N., Buck D.W., He D., Reitsma M.J., Masek M., Phan T.V. et al.: Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA. 2000, 97, 14720–14725.

Clement V., Marino D., Cudalbu C., Hamou M.F., Mlynarik V., de Tri bolet N. et al.: Marker independent identification of glioma initiating cells. Nat Methods. 2010, 7 (3), 224–228.

Sampetrean O., Saya H.: Characteristics of glioma stem cells. Brain Tumor Pathol. 2013, 30 (4), 209–214.

Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B. et al.: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006, 444, 756–760.


Copyright (c) 2016 Paweł Wańkowicz, Przemysław Nowacki

License URL: